Other
Exercise Training
0
Pipeline Programs↗
1
Active Trials↗
2
Companies Involved↗
Exercise Training is an early-stage landscape with 0 programs across 2 companies. The most active players are Metro International Biotech, LLC, Silvia Ulrich Somaini.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed9 · 75%
Recruiting1 · 8%
Withdrawn1 · 8%
Unknown status1 · 8%
Clinical Trials
Trial Activity
12 trials
Exercise Training Versus Drug Therapy for Treating Depression in Older Adults
Completed·—·Phase 3·NCT00331305·457 enrolled
Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
Completed·—·Phase 2·NCT01785524·18 enrolled
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
Completed·—·Phase 2·NCT02371187·37 enrolled
Ectopic Adipose Tissue, Exercise Training and IL-6
Completed·—·N/A·NCT02901496·83 enrolled
Eccentric Cycling Exercise During Pulmonary Rehabilitation in Patients With Cardiopulmonary Diseases
Completed·—·Preclinical·NCT07042750·22 enrolled
Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training
Withdrawn·—·Phase 1·NCT03972683
Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness
Unknown status·—·Phase 2·NCT03824834·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)